In this study, we evaluated the expression and clinical relevance of the Tim-3 signaling pathway in a large set of prostate samples, including BPH, PIN, localized PCa, and metastatic PCa. This evidence concerns the gene HAVCR2 and benign prostatic hyperplasia.